Manipulating the anabolic and catabolic response in bone graft remodeling: Synergism by a combination of local BMP-7 and a single systemic dosis of zoledronate

Journal of Orthopaedic Research

Volumn 26, Issue 9, 2008, Pages 1245-1249

  Harding, Anna Kajsa ^a   Aspenberg, Per ^b   Kataoka, Masashi ^a,c   Bylski, David ^a   Tägil, Magnus ^a   Aharinejad, Seyedhossein ^d  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c OITA UNIVERSITY   (Japan)

^d NONE

Author keywords

Anabolism; Bisphosphonates; Bone graft remodeling; Bone morphogenic protein (BMP); Catabolism

Indexed keywords

RECOMBINANT OSTEOGENIC PROTEIN 1; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; BONE MORPHOGENETIC PROTEIN; IMIDAZOLE DERIVATIVE; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; BONE GRAFT; BONE GROWTH; BONE REMODELING; CATABOLISM; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BONE TRANSPLANTATION; COMPARATIVE STUDY; DRUG COMBINATION; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIBIA;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; BONE TRANSPLANTATION; DIPHOSPHONATES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; IMIDAZOLES; RATS; RATS, SPRAGUE-DAWLEY; TIBIA; TRANSFORMING GROWTH FACTOR BETA;

EID: 49149097693     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20625     Document Type: Article

References (19)

1. Little DG, Ramachandran M, Schindeler A. 2007. The anabolic and catabolic responses in bone repair. J Bone Joint Surg [Br] 89B:425-433.
2. Aspenberg P, Wang JS. 1993. A new bone chamber used for measuring osteoconduction in rats. Eur J Exp Musculoskel Res 2:69-74.
3. Rogers MJ. 2003. New insights into the molecular mechanisms of action of bisphosphonates [review]. Curr Pharm Des 9:2643-2658.
4. Åstrand J, Aspenberg P. 2002. Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats. BMC Musculoskelet Disord 3:19.
5. Amanat N, Brown R, Bilston LE, et al. 2005. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair. J Orthop Res 23:1029-1034.
6. Kanatani M, Sugimoto T, Kaij H, et al. 1995. Stimulatory effect of bone morphogenicprotein-2 on osteoclastlike cell formation and bone resorbing activity. J Bone Min Res 10: 1681-1690.
7. Okamoto M, Murai J, Yoshikawa H, et al. 2006. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res 21:1022-1033.
8. Tägil M, Jeppsson C, Aspenberg P. 2000. Bone graft incorporation. Effects of osteogenic protein-1 and impaction. Clin Orthop 371:240-245.
9. Jeppsson C, Astrand J, Tagil M, et al. 2003. A combination of bisphosphonate and BMP additives in impacted bone allografts. Acta Orthop Scand 74:483-489.
10. Friedlaender GE, Perry CR, Cole JD, et al. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg [Am] 83 (Suppl 1):S151-S158.
11. Govender S, Csimma C, Genant HK, et al. 2002. BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg [Am] 84A:2123-2134.
12. Ästrand J, Harding AK, Aspenberg P, et al. 2006. Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodeling. A bone chamber study in rats. BMC Musculoskelet Disord 47:63.
13. Little DG, McDonald M, Bransford R, et al. 2005. Manipulation of the anabolic and catabolic responses with BMP-7 (OSIGRAFT) and zoledronic acid in a rat critical defect model. J Bone Miner Res 20:2044-2052.
14. Tägil M, Aspenberg P, Ästrand J. 2006. Systemic zoledronate precoating of a bone graft reduces bone resorption during remodeling. Acta Orthop 77:23-26.
15. Kaneko H, Arakawa T, Mano H, et al. 2000. Direct stimulation of osteoclastic bone resorption by bone morphogenic protein (BMP-2) and expression of BMP receptors in mature osteoclasts. Bone 27:479-486.
16. Bostrom MP, Aspenberg P, Jeppsson C, et al. 1998. Enhancement of bone formation in the setting of repeated tissue deformation. Clin Orthop 350:221-228.
17. Tägil M, Jeppsson C, Wang JS, et al. 2003. No augmentation of morselized and impacted bone graft by BMP-7 (OSIGRAFT) in a weight-bearing model. Acta Orthop Scand 74:742-748.
18. Kärrholm J, Hourigan P, Timperley J, et al. 2006. Mixing bone graft with BMP-7 (OSIGRAFT) does not improve cup or stem fixation in revision surgery of the hip: 5-year follow-up of 10 acetabular and 11 femoral study cases and 40 control cases. Acta Orthop 77:39-48.
19. Im GI, Qureshi SA, Kenney J, et al. 2004. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25:4105-4115.